Naltrexone Inhibits Catecholamine Secretion Evoked by Nicotinic Receptor Stimulation in the Perfused Rat Adrenal Medulla
![]() |
Yu, Byung-Sik
(Departments of Anesthesiology, College of Medicine, Chosun University)
Min, Seon-Young (Departments of Pharmacology, College of Medicine, Chosun University) Seo, Yoo-Seok (Departments of Pharmacology, College of Medicine, Chosun University) Choi, Cheol-Hee (Departments of Pharmacology, College of Medicine, Chosun University) Lee, Eun-Hwa (Department of Medical and Pharmaceuticals, Chodang University) Lim, Dong-Yoon (Departments of Pharmacology, College of Medicine, Chosun University) |
1 |
Albillos A, Carbone E, Gandia L, Garcia AG, Pollo A. Opioid inhibition of |
2 |
Cheek TR, O'Sullivan AJ, Moreton RB, Berridge MJ, Burgoyne RD. Spatial localization of the stimulus-induced rise in cytosolic |
3 |
Kitamura G, Ohta T, Kai T, Kon Y, Ito S. Inhibitory effects of opioids on voltage-dependent Ca ( |
4 |
Kleppisch T, Ahnert-Hilger G, Gollasch M, Spicher K, Hescheler J, Schultz G, Rosenthal W. Inhibition of voltage-dependent |
5 | Kumakura K, Karoum F, Guidotti A, Costa E. Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells. Nature 283: 489-492, 1980 DOI ScienceOn |
6 | Ritchie AK. Catecholamine secretion in a rat pheochromocytoma cell line: Two pathways for calcium entry. J Physiol 286: 541- 561, 1979 DOI PUBMED |
7 |
Twitchell WA, Rane SG. Opioid peptide modulation of Neuron -dependent |
8 | Wakade AR. Studies on secretion of catecholamines evoked by ACh or transmural stimulation of the rat adrenal gland. J Physiol 313: 463-480, 1981 PUBMED |
9 | Winkler H, Westhead E. The molecular organization of adrenal chromaffin granules. Neuroscience 5: 1803-1823, 1980 DOI PUBMED ScienceOn |
10 | Anton AH, Sayre DF. A study of the factors affecting the aluminum oxidetrihydroxy indole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360-375, 1962 PUBMED |
11 |
Artalejo CR, Adams ME, Fox AP. Three types of |
12 | Dean DM, Lemaire S, Livett BG. Evidence that inhibition of nicotine- mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors. J Neurochem 38: 606-614, 1982 DOI PUBMED |
13 | Dermitzaki E, Gravanis A, Venihaki M, Stournaras C, Margioris AN. Opioids suppress basal and nicotine-induced catecholamine secretion via a stabilizing effect on actin filaments. Endocrinology 142: 2022-2031, 2001 DOI ScienceOn |
14 | Lemaire S, Day R, Dumont M, Chouinard L, Calvert R. Dynorphin and enkephalins in adrenal paraneurons. Opiates in adrenal medulla. Can J Physiol Pharmacol 62: 484-492, 1984 DOI PUBMED ScienceOn |
15 | Jarry H, Dietrich M, Barthel A, Giesler A, Wuttke W. In vivo demonstration of a paracrine, inhibitory action of Met-enkephalin on adrenomedullary catecholamine release in the rat. Endocrinology 125: 624-629, 1989 DOI ScienceOn |
16 | Lim DY, Lee JJ, Choi CH. Effect of opioid on nicotinic receptormediated catecholamine secretion in the rat adrenal gland. Korean J Pharmacol 28: 181-190, 1992 |
17 | Owen PJ, Marriott DB, Boarder MR. Evidence for a dihydropyridine- sensitive and conotoxin-insensitive release of noradrenaline and uptake of calcium in adrenal chromaffin cells. Br J Pharmacol 97: 133-138, 1989 DOI PUBMED ScienceOn |
18 | DougIas WW, Kanno T, Sampson SR. Effects of acetylcholine and other medullary secretagogues and antagonists on the membrane potential of adrenal chromaffin cells: An analysis employing techniques of tissue culture. J Physiol 188: 107-120, 1967 DOI PUBMED |
19 | O'Farrell N, Zigas J, Marley PD. Effect of N- and L-type calcium channel antagonists and (t)-Bay-K-8644 on nerve-induced catecholamine secretion from bovine perfused adrenal glands. Br J Pharmacol 121: 381-388, 1997 DOI PUBMED ScienceOn |
20 | Challis RAJ, Jones JA, Owen PJ, Boarder MR. Changes in inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate mass accumulations in cultured adrenal chromaffin cells in response to bradykinin and histamine. J Neurochem 56: 1083-1086, 1991 DOI PUBMED |
21 |
Goeger DE, Riley RT. Interaction of cyclopiazonic acid with rat skeletal muscle sarcoplasmic reticulum vesicles. Effect on Ca2+ binding and |
22 |
Seidler NW, Jona I, Vegh N, Martonosi A. Cyclopiazonic acid is a specific inhibitor of the |
23 | Boarder MR, Marriott D, Adams M. Stimulus secretion coupling in cultured chromaffin cells, dependency on external sodium and on dihydropyridine-sensitive calcium channels. Biochem Pharmacol 36: 163-167, 1987 DOI ScienceOn |
24 | Cena V, Nicholas G, Sanchez-Garcia P, Kirpekar SM, Garcia AG. Pharmacological dissection of receptor-associated and voltagesensitive ionic channels involved in catecholamine release. Neuroscience 10: 1455-1462, 1983 DOI ScienceOn |
25 | Hammer R, Giachetti A. Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci 31: 2992- 2998, 1982 |
26 | Lopez MG, Fonteriz R, Gandia L, De la Fuente M, Villarroya M, Garcia-Sancho J, Garcia AG. The nicotinic ACh receptor of the bovine chromaffin cell, a new target for dihydropyridines. Eur J Pharmacol Molec Biol 247: 199-207, 1993 DOI ScienceOn |
27 | Bunn SJ, Dunkley PR. Opioid inhibition of nicotine-induced 45Ca2 (+)-uptake into cultured bovine adrenal medullary cells. Biochem Pharmacol 41: 715-722, 1991 DOI ScienceOn |
28 | Douglas WW, Kanno T, Sampson SR. Influence of the ionic environment on the membrane potential of adrenal cells and on the depolarizing effect of acetylcholine. J Physiol 191: 107-121, 1967 DOI PUBMED |
29 | Marley PD, Livett BG. Effects of opioid compounds on desensitization of the nicotinic response of isolated bovine adrenal chromaffin cells. Biochem Pharmacol 36: 2937-2944, 1987 DOI ScienceOn |
30 | Saiani L, Guidotti A. Opiate receptor-mediated inhibition of catecholamine release in primary cultures of bovine adrenal chromaffin cells. J Neurochem 39: 1669-1676, 1982 DOI PUBMED |
31 |
Suzuki M, Muraki K, Imaizumi Y, Watanabe M. Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum |
32 | Mannelli M, Maggi M, DeFeo ML, Boscaro M, Opocher G, Mantero F, Baldi E, Giusti G. Opioid modulation of normal and pathological human chromaffin tissue. J Clin Endocrinol Metab 62: 577-582, 1986 DOI PUBMED |
33 | Tome AR, Izaguirre V, Rosario LM, Cena V, Gonzalez-Garcia C. Naloxone inhibits nicotine-induced receptor current and catecholamine secretion in bovine chromaffin cells. Brain Res 903: 62-65, 2001 DOI PUBMED ScienceOn |
34 |
Marley PD, Mitchelhill KI, Livett BG. Effects of opioid peptides containing the sequence of |
35 |
Uyama Y, Imaizumi Y, Watanabe M. Effects of cyclopiazonic acid, a novel |
36 | Venihaki M, Ain K, Gravanis A, Margioris AN. KAT45, a noradrenergic human pheochromocytoma cell line producing corticotropin- releasing hormone. Endocrinology 139: 713-722, 1998 DOI ScienceOn |
37 | Epple A, Nibbio B, Spector S, Brinn JE. Endogenous codeine: autocrine regulator of catecholamine release from chromaffin cells. Life Sci 54: 695-702, 1994 DOI ScienceOn |
38 | Lim DY, Kim CD, Ahn KW. Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch Pharm Res 15: 115-125, 1992 DOI ScienceOn |
39 | Venihaki M, Gravanis A, Margioris AN. Opioids inhibit dopamine secretion from PC12 rat pheochromocytoma cells in a naloxonereversible manner. Life Sci 58: 75-82, 1996 DOI PUBMED ScienceOn |
40 | Livett BG, Dean DM, Whelan LG, Udenfriend S, Rossier J. Corelease of enkephalin and catecholamines from cultured adrenal chromaffin cells. Nature 289: 317-319, 1981 DOI ScienceOn |
41 | Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fonteriz R, Gandia L. Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature 309: 69-71, 1984. DOI ScienceOn |
42 | Barron BA, Hexum TD. Modulation of bovine adrenal gland secretion by etorphine and diprenorphine. Life Sci 38: 935-940, 1986 DOI ScienceOn |
43 | Dendorfer A, Dominiak P. Characterisation of bradykinin receptors mediating catecholamine release in PC12 cells. Naunyn-Schmiedeberg's Arch Pharmacol 351: 274-281, 1995 |
44 | Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Gilman AG, Limbird LE ed, Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, p 521-556, 1996 |
45 | Conway EL, Brown MJ, Dollery CT. Studies on the pharmacology of central opioid-induced increases in plasma catecholamines in conscious rats. Neuropharmacol 23: 1291-1296, 1984 DOI ScienceOn |
46 | Livett BG, Boksa P. Receptors and receptor modulation in cultured chromaffin cells. Can J Physiol Pharmacol 62: 467-476, 1984 DOI PUBMED ScienceOn |
47 | Albillos A, Gandia L, Michelena P, Gilabert JA, del Valle M, Carbone E, Garcia AG. The mechanism of calcium channel facilitation in bovine chromaffin cells. J Physiol 494: 687-695, 1996 DOI PUBMED |
48 | Ilno M. Calcium-induced calcium release mechanism in guinea pig taenia caeci. J Gen Physiol 94: 363-383, 1989 DOI PUBMED ScienceOn |
49 | Kimura T, Katoh M, Satoh S. Inhibition by opioid agonists and enhancement by antagonists of the release of catecholamines from the dog adrenal gland in response to splanchnic nerve stimulation: Evidence for the functional role of opioid receptors. J Pharmacol Exp Ther 244: 1098-1102, 1988 PUBMED |
50 | Tallarida RJ, Murray RB. Manual of pharmacologic calculation with computer programs. 2nd ed. Speringer-Verlag, New York, p 132, 1987 |
![]() |